The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases.EBI
University of Montpellier
Recent advances in the development of methyltransferase (MTase) inhibitors against (re)emerging arboviruses diseases dengue and Zika.EBI
Instituto Politecnico Nacional
Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.EBI
University of Montpellier
Druggable targets from coronaviruses for designing new antiviral drugs.EBI
Federal University of Alagoas
Design, synthesis and in vitro anti-Zika virus evaluation of novel Sinefungin derivatives.EBI
Peking Union Medical College
Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors.EBI
New Mexico Institute of Mining and Technology